Mohamed ElSayed

Company: RVAC Medicines

Job title: EVP & CTO

Seminars:

Roundtable Discussion: Reviewing the Next Generation of RNA Technologies as an Alternative Candidate for Use in Cancer Vaccines 11:30 am

Revealing how sa-RNA is capable of inducing a strong immune response in the body allowing it to be an ideal candidate for use in cancer vaccines Showing how circular-RNA has been found to be more stable and resistant to degradation than other forms of RNA Investigating how si-RNA is capable of silencing specific genes that…Read more

day: Conference Day One